-
2
-
-
32644435902
-
COPD exacerbations 1: Epidemiology
-
G.C. Donaldson, J.A. Wedzicha COPD exacerbations 1: Epidemiology Thorax 61 2006 164 168
-
(2006)
Thorax
, vol.61
, pp. 164-168
-
-
Donaldson, G.C.1
Wedzicha, J.A.2
-
3
-
-
33646352211
-
Clinical assessment, staging, and epidemiology of chronic obstructive pulmonary disease exacerbations
-
DOI 10.1513/pats.200510-107SF
-
J. Vestbo Clinical assessment, staging, and epidemiology of chronic obstructive pulmonary disease exacerbations Proc Am Thorac Soc 3 2006 252 256 (Pubitemid 43668190)
-
(2006)
Proceedings of the American Thoracic Society
, vol.3
, Issue.3
, pp. 252-256
-
-
Vestbo, J.1
-
4
-
-
24644439190
-
Trends in the leading causes of death in the United States, 1970-2002
-
DOI 10.1001/jama.294.10.1255
-
A. Jemal, E. Ward, Y. Hao et al. Trends in the leading causes of death in the United States, 1970-2002 JAMA 294 2005 1255 1259 (Pubitemid 41352114)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.10
, pp. 1255-1259
-
-
Jemal, A.1
Ward, E.2
Hao, Y.3
Thun, M.4
-
5
-
-
0031001720
-
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
-
DOI 10.1016/S0140-6736(96)07492-2
-
C.J. Murray, A.D. Lopez Alternative projections of mortality and disability by cause 19902020: Global Burden of Disease Study Lancet 349 1997 1498 1504 (Pubitemid 27216360)
-
(1997)
Lancet
, vol.349
, Issue.9064
, pp. 1498-1504
-
-
Murray, C.J.L.1
Lopez, A.D.2
-
6
-
-
1842457093
-
A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease
-
DOI 10.1111/j.1524-4733.2004.72318.x
-
S. Borg, A. Ericsson, J. Wedzicha et al. A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease Value Health 7 2004 153 167 (Pubitemid 38420728)
-
(2004)
Value in Health
, vol.7
, Issue.2
, pp. 153-167
-
-
Borg, S.1
Ericsson, A.2
Wedzicha, J.3
Gulsvik, A.4
Lundback, B.5
Donaldson, G.C.6
Sullivan, S.D.7
-
7
-
-
1242315575
-
Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity
-
DOI 10.1016/j.amjmed.2003.09.027
-
D.D. Sin, K. Golmohammadi, P. Jacobs Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity Am J Med 116 2004 325 331 (Pubitemid 38230292)
-
(2004)
American Journal of Medicine
, vol.116
, Issue.5
, pp. 325-331
-
-
Sin, D.D.1
Golmohammadi, K.2
Jacobs, P.3
-
8
-
-
22244479358
-
Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease
-
DOI 10.2165/00019053-200523060-00008
-
M. Spencer, A.H. Briggs, R.F. Grossman et al. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease Pharmacoeconomics 23 2005 619 637 (Pubitemid 40994129)
-
(2005)
PharmacoEconomics
, vol.23
, Issue.6
, pp. 619-637
-
-
Spencer, M.1
Briggs, A.H.2
Grossman, R.F.3
Rance, L.4
-
9
-
-
23144437068
-
A dynamic population model of disease progression in COPD
-
DOI 10.1183/09031936.05.00122004
-
M. Hoogendoorn, M.P. Rutten-van Molken, R.T. Hoogenveen et al. A dynamic population model of disease progression in COPD Eur Respir J 26 2005 223 233 (Pubitemid 41079065)
-
(2005)
European Respiratory Journal
, vol.26
, Issue.2
, pp. 223-233
-
-
Hoogendoorn, M.1
Rutten-Van Molken, M.P.M.H.2
Hoogenveen, R.T.3
Van Genugten, M.L.L.4
Buist, A.S.5
Wouters, E.F.M.6
Feenstra, T.L.7
-
10
-
-
14344257828
-
Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries
-
DOI 10.1111/j.1524-4733.2005.03086.x
-
J.B. Oostenbrink, M.P. Rutten-van Molken, B.U. Monz et al. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries Value Health 8 2005 32 46 (Pubitemid 40293639)
-
(2005)
Value in Health
, vol.8
, Issue.1
, pp. 32-46
-
-
Oostenbrink, J.B.1
Rutten-Van Molken, M.P.M.H.2
Monz, B.U.3
FitzGerald, J.M.4
-
11
-
-
34547617931
-
Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
-
N.R. Dal, M. Eandi, L. Pradelli et al. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients Int J Chron Obstruct Pulmon Dis 2 2007 169 176 (Pubitemid 47202217)
-
(2007)
International Journal of COPD
, vol.2
, Issue.2
, pp. 169-176
-
-
Dal Negro, R.1
Eandi, M.2
Pradelli, L.3
Iannazzo, S.4
-
12
-
-
60749089756
-
Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease
-
A. Chuck, P. Jacobs, I. Mayers et al. Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease Can Respir J 15 2008 437 443
-
(2008)
Can Respir J
, vol.15
, pp. 437-443
-
-
Chuck, A.1
Jacobs, P.2
Mayers, I.3
-
13
-
-
70349646763
-
Present and future costs of COPD in Iceland and Norway: Results from the BOLD study
-
R. Nielsen, A. Johannessen, B. Benediktsdottir et al. Present and future costs of COPD in Iceland and Norway: results from the BOLD study Eur Respir J 34 2009 850 857
-
(2009)
Eur Respir J
, vol.34
, pp. 850-857
-
-
Nielsen, R.1
Johannessen, A.2
Benediktsdottir, B.3
-
14
-
-
58049090292
-
Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD
-
S.R. Earnshaw, M.R. Wilson, A.A. Dalal et al. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD Respir Med 103 2009 12 21
-
(2009)
Respir Med
, vol.103
, pp. 12-21
-
-
Earnshaw, S.R.1
Wilson, M.R.2
Dalal, A.A.3
-
15
-
-
33748806056
-
Economic modeling in chronic obstructive pulmonary disease
-
DOI 10.1513/pats.200603-095SS
-
M. Rutten-van Molken, T.A. Lee Economic modeling in chronic obstructive pulmonary disease Proc Am Thorac Soc 3 2006 630 634 (Pubitemid 44411632)
-
(2006)
Proceedings of the American Thoracic Society
, vol.3
, Issue.7
, pp. 630-634
-
-
Molken, M.R.-V.1
Lee, T.A.2
-
16
-
-
0034086702
-
Handling uncertainty in cost-effectiveness models
-
A.H. Briggs Handling uncertainty in cost-effectiveness models Pharmacoeconomics 17 2000 479 500 (Pubitemid 30398806)
-
(2000)
PharmacoEconomics
, vol.17
, Issue.5
, pp. 479-500
-
-
Briggs, A.H.1
-
17
-
-
17144409710
-
Probabilistic sensitivity analysis for NICE technology assessment: Not an optional extra
-
DOI 10.1002/hec.985
-
K. Claxton, M. Sculpher, C. McCabe et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra Health Econ 14 2005 339 347 (Pubitemid 40514748)
-
(2005)
Health Economics
, vol.14
, Issue.4
, pp. 339-347
-
-
Claxton, K.1
Sculpher, M.2
McCabe, C.3
Briggs, A.4
Akehurst, R.5
Buxton, M.6
Brazier, J.7
O'Hagan, T.8
-
18
-
-
77956031239
-
Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
-
M. Hoogendoorn, T.L. Feenstra, R.T. Hoogenveen et al. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD Thorax 65 2010 711 718
-
(2010)
Thorax
, vol.65
, pp. 711-718
-
-
Hoogendoorn, M.1
Feenstra, T.L.2
Hoogenveen, R.T.3
-
19
-
-
82955247237
-
Meta-analysis of FEV1 as a risk factor for all-cause mortality
-
M.P.M.H. Rutten-van Molken, R.T. Hoogenveen, T.L. Feenstra et al. Meta-analysis of FEV1 as a risk factor for all-cause mortality Eur Respir J 22 Suppl. 45 2003 P3047
-
(2003)
Eur Respir J
, vol.22
, Issue.SUPPL. 45
, pp. 3047
-
-
Rutten-Van Molken, M.P.M.H.1
Hoogenveen, R.T.2
Feenstra, T.L.3
-
20
-
-
84857030690
-
-
[Accessed February 15, 2011]
-
M. Hoogendoorn, M.P.M.H. Rutten-van Mölken, R.T. Hoogenveen et al. Working paper: comparing the cost-effectiveness of a wide range of COPD interventions using a stochastic, dynamic, population model for COPD http://www.bmg.eur.nl/fileadmin/ASSETS/bmg/Onderzoek/Onderzoeksrapporten- Working-Papers/OR2010.01.pdf 2010 [Accessed February 15, 2011]
-
(2010)
Working Paper: Comparing the Cost-effectiveness of A Wide Range of COPD Interventions Using A Stochastic, Dynamic, Population Model for COPD
-
-
Hoogendoorn, M.1
Rutten-Van Mölken, M.P.M.H.2
Hoogenveen, R.T.3
-
22
-
-
34250644441
-
Health status impairment and costs associated with COPD exacerbation managed in hospital
-
DOI 10.1111/j.1742-1241.2007.01424.x
-
J.F. O'Reilly, A.E. Williams, L. Rice Health status impairment and costs associated with COPD exacerbation managed in hospital Int J Clin Pract 61 2007 1112 1120 (Pubitemid 46934632)
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.7
, pp. 1112-1120
-
-
O'Reilly, J.F.1
Williams, A.E.2
Rice, L.3
-
26
-
-
41049097488
-
Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation
-
R.T. Hoogenveen, P.H. van Baal, H.C. Boshuizen et al. Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation Cost Eff Resour Alloc 6 2008 1
-
(2008)
Cost Eff Resour Alloc
, vol.6
, pp. 1
-
-
Hoogenveen, R.T.1
Van Baal, P.H.2
Boshuizen, H.C.3
-
29
-
-
0003649181
-
-
US Department of Health and Human Services Hyattsville, MD DHHS Publication No. (CDC) 90-8416
-
The Health Benefits of Smoking Cessation 1990 US Department of Health and Human Services Hyattsville, MD DHHS Publication No. (CDC) 90-8416
-
(1990)
The Health Benefits of Smoking Cessation
-
-
-
30
-
-
26044441678
-
-
Volksgezondheid Toekomst Verkenning City, Country
-
J.A.M. van Oers Gezondheid op koers? 2002 Volksgezondheid Toekomst Verkenning City, Country
-
(2002)
Gezondheid Op Koers?
-
-
Van Oers, J.A.M.1
-
31
-
-
29844456024
-
Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice
-
DOI 10.1016/j.rmed.2005.04.004, PII S0954611105001587
-
M. Hoogendoorn, T.L. Feenstra, T.R. Schermer et al. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice Respir Med 100 2006 83 86 (Pubitemid 43033383)
-
(2006)
Respiratory Medicine
, vol.100
, Issue.1
, pp. 83-86
-
-
Hoogendoorn, M.1
Feenstra, T.L.2
Schermer, T.R.J.3
Hesselink, A.E.4
Rutten-Van Molken, M.P.M.H.5
-
32
-
-
0027962628
-
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1 the Lung Health Study
-
N.R. Anthonisen, J.E. Connett, J.P. Kiley et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1 The Lung Health Study JAMA 272 1994 1497 1505
-
(1994)
JAMA
, vol.272
, pp. 1497-1505
-
-
Anthonisen, N.R.1
Connett, J.E.2
Kiley, J.P.3
-
33
-
-
0034063821
-
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: The lung health study
-
P.D. Scanlon, J.E. Connett, L.A. Waller et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease The Lung Health Study Am J Respir Crit Care Med 161 2 Pt 1 2000 381 390 (Pubitemid 30129442)
-
(2000)
American Journal of Respiratory and Critical Care Medicine
, vol.161
, Issue.2
, pp. 381-390
-
-
Scanlon, P.D.1
Connett, J.E.2
Waller, L.A.3
Altose, M.D.4
Bailey, W.C.5
Buist, A.S.6
Tashkin, D.P.7
-
34
-
-
82955168570
-
-
Statistic Netherlands The Hague, Netherlands
-
All-cause mortality 2006 Statistic Netherlands The Hague, Netherlands
-
(2006)
All-cause Mortality
-
-
-
36
-
-
79960383347
-
-
Statistic Netherlands The Hague, Netherlands
-
Consumer Price Indices 2008 Statistic Netherlands The Hague, Netherlands
-
(2008)
Consumer Price Indices
-
-
-
37
-
-
34247368146
-
Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease
-
DOI 10.1093/intqhc/mzl052
-
L. Steuten, B. Vrijhoef, F. Van Merode et al. Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease Int J Qual Health Care 18 2006 429 436 (Pubitemid 44823773)
-
(2006)
International Journal for Quality in Health Care
, vol.18
, Issue.6
, pp. 429-436
-
-
Steuten, L.1
Vrijhoef, B.2
Van Merode, F.3
Wesseling, G.-J.4
Spreeuwenberg, C.5
-
39
-
-
79953674776
-
Case-fatality of COPD exacerbations: A meta-analysis and statistical modeling approach
-
M. Hoogendoorn, R.T. Hoogenveen, M.P. Rutten-van Molken et al. Case-fatality of COPD exacerbations: a meta-analysis and statistical modeling approach Eur Respir J 37 2011 508 515
-
(2011)
Eur Respir J
, vol.37
, pp. 508-515
-
-
Hoogendoorn, M.1
Hoogenveen, R.T.2
Rutten-Van Molken, M.P.3
-
40
-
-
0036794862
-
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
-
DOI 10.1136/thorax.57.10.847
-
G.C. Donaldson, T.A. Seemungal, A. Bhowmik et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852 (Pubitemid 35178607)
-
(2002)
Thorax
, vol.57
, Issue.10
, pp. 847-852
-
-
Donaldson, G.C.1
Seemungal, T.A.R.2
Bhowmik, A.3
Wedzicha, J.A.4
-
41
-
-
34247639520
-
Exacerbations and lung function decline in COPD: New insights in current and ex-smokers
-
DOI 10.1016/j.rmed.2006.10.012, PII S0954611106005099
-
D. Makris, J. Moschandreas, A. Damianaki et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers Respir Med 101 2007 1305 1312 (Pubitemid 46667662)
-
(2007)
Respiratory Medicine
, vol.101
, Issue.6
, pp. 1305-1312
-
-
Makris, D.1
Moschandreas, J.2
Damianaki, A.3
Ntaoukakis, E.4
Siafakas, N.M.5
Milic Emili, J.6
Tzanakis, N.7
-
42
-
-
0035422691
-
1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: Results from the Lung Health Study
-
R.E. Kanner, N.R. Anthonisen, J.E. Connett Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study Am J Respir Crit Care Med 164 2001 358 364 (Pubitemid 32778199)
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.164
, Issue.3
, pp. 358-364
-
-
Kanner, R.E.1
Anthonisen, N.R.2
Connett, J.E.3
-
43
-
-
2442552129
-
Impact of preventing exacerbations on deterioration of health status in COPD
-
DOI 10.1183/09031936.04.00121404
-
S. Spencer, P.M. Calverley, P.S. Burge et al. Impact of preventing exacerbations on deterioration of health status in COPD Eur Respir J 23 2004 698 702 (Pubitemid 38618138)
-
(2004)
European Respiratory Journal
, vol.23
, Issue.5
, pp. 698-702
-
-
Spencer, S.1
Calverley, P.M.A.2
Burge, P.S.3
Jones, P.W.4
-
44
-
-
48949103222
-
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study
-
B.R. Celli, N.E. Thomas, J.A. Anderson et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am J Respir Crit Care Med 178 2008 332 338
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 332-338
-
-
Celli, B.R.1
Thomas, N.E.2
Anderson, J.A.3
-
45
-
-
4043134574
-
Resource use and risk factors in high-cost exacerbations of COPD
-
DOI 10.1016/j.rmed.2004.02.013, PII S0954611104000824
-
J.B. Oostenbrink, M.P. Rutten-van Molken Resource use and risk factors in high-cost exacerbations of COPD Respir Med 98 2004 883 891 (Pubitemid 39069339)
-
(2004)
Respiratory Medicine
, vol.98
, Issue.9
, pp. 883-891
-
-
Oostenbrink, J.B.1
Rutten-Van Molken, M.P.M.H.2
-
46
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
DOI 10.1056/NEJMoa063070
-
P.M. Calverley, J.A. Anderson, B. Celli et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789 (Pubitemid 46294610)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.8
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.3
Ferguson, G.T.4
Jenkins, C.5
Jones, P.W.6
Yates, J.C.7
Vestbo, J.8
-
47
-
-
75149179709
-
Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?
-
M. Hoogendoorn, C.R. van Wetering, A.M. Schols et al. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J 35 2010 79 87
-
(2010)
Eur Respir J
, vol.35
, pp. 79-87
-
-
Hoogendoorn, M.1
Van Wetering, C.R.2
Schols, A.M.3
-
49
-
-
0028509556
-
Costs, effects and C/E-ratios alongside a clinical trial
-
B.A. van Hout, M.J. Al, G.S. Gordon et al. Costs, effects and C/E-ratios alongside a clinical trial Health Econ 3 1994 309 319
-
(1994)
Health Econ
, vol.3
, pp. 309-319
-
-
Van Hout, B.A.1
Al, M.J.2
Gordon, G.S.3
-
50
-
-
0035669803
-
Representing uncertainty: The role of cost-effectiveness acceptability curves
-
DOI 10.1002/hec.635
-
E. Fenwick, K. Claxton, M. Sculpher Representing uncertainty: the role of cost-effectiveness acceptability curves Health Econ 10 2001 779 787 (Pubitemid 34041389)
-
(2001)
Health Economics
, vol.10
, Issue.8
, pp. 779-787
-
-
Fenwick, E.1
Claxton, K.2
Sculpher, M.3
-
51
-
-
2442652725
-
Cost-effectiveness acceptability curves - Facts, fallacies and frequently asked questions
-
DOI 10.1002/hec.903
-
E. Fenwick, B.J. O'Brien, A. Briggs Cost-effectiveness acceptability curvesfacts, fallacies and frequently asked questions Health Econ 13 2004 405 415 (Pubitemid 38660390)
-
(2004)
Health Economics
, vol.13
, Issue.5
, pp. 405-415
-
-
Fenwick, E.1
O'Brien, B.J.2
Briggs, A.3
-
52
-
-
28844508639
-
Smoking cessation in patients with COPD in daily general practice (SMOCC): Six months' results
-
DOI 10.1016/j.ypmed.2005.08.003, PII S0091743505001180
-
S.R. Hilberink, J.E. Jacobs, B.J. Bottema et al. Smoking cessation in patients with COPD in daily general practice (SMOCC): six months' results Prev Med 41 2005 822 827 (Pubitemid 41772657)
-
(2005)
Preventive Medicine
, vol.41
, Issue.5-6
, pp. 822-827
-
-
Hilberink, S.R.1
Jacobs, J.E.2
Bottema, B.J.A.M.3
De Vries, H.4
Grol, R.P.T.M.5
-
53
-
-
1442306237
-
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
-
DOI 10.1056/NEJMoa021322
-
B.R. Celli, C.G. Cote, J.M. Marin et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012 (Pubitemid 38269277)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.10
, pp. 1005-1012
-
-
Celli, B.R.1
Cote, C.G.2
Marin, J.M.3
Casanova, C.4
Montes De Oca, M.5
Mendez, R.A.6
Plata, V.P.7
Cabral, H.J.8
-
54
-
-
72549113283
-
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: The DOSE Index
-
R.C. Jones, G.C. Donaldson, N.H. Chavannes et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index Am J Respir Crit Care Med 180 2009 1189 1195
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 1189-1195
-
-
Jones, R.C.1
Donaldson, G.C.2
Chavannes, N.H.3
-
55
-
-
69149083159
-
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: The updated BODE index and the ADO index
-
M.A. Puhan, J. Garcia-Aymerich, M. Frey et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index Lancet 374 2009 704 711
-
(2009)
Lancet
, vol.374
, pp. 704-711
-
-
Puhan, M.A.1
Garcia-Aymerich, J.2
Frey, M.3
-
56
-
-
16844379129
-
Assessment of progression of COPD: Report of a workshop held in Leuven, 11-12 March 2004
-
DOI 10.1136/thx.2004.028712
-
M. Decramer, R. Gosselink, M. Rutten-Van Molken et al. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004 Thorax 60 2005 335 342 (Pubitemid 40522372)
-
(2005)
Thorax
, vol.60
, Issue.4
, pp. 335-342
-
-
Decramer, M.1
Gosselink, R.2
Rutten-Van Molken, M.3
Buffels, J.4
Van Schayck, O.5
Gevenois, P.-A.6
Pellegrino, R.7
Derom, E.8
De Backer, W.9
|